These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 8813234

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Levodopa-associated hemifacial dystonia.
    Mark MH, Sage JI.
    Mov Disord; 1991; 6(4):383. PubMed ID: 1758464
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Square-wave action dystonia in Parkinson's disease.
    van den Munckhof P, Lenz FA, Chase TN.
    Mov Disord; 1998 Mar; 13(2):354-6. PubMed ID: 9539355
    [No Abstract] [Full Text] [Related]

  • 5. [Pharmacological therapy of complicated Parkinson's disease].
    Jiménez-Jiménez FJ, Molina JA.
    Rev Neurol; 1997 Aug; 25 Suppl 2():S170-9. PubMed ID: 9280685
    [Abstract] [Full Text] [Related]

  • 6. Parkinson's disease.
    Clarke C, Moore AP.
    Clin Evid; 2002 Jun; (7):1208-20. PubMed ID: 12230738
    [No Abstract] [Full Text] [Related]

  • 7. Parkinson's disease.
    Clarke C, Moore A.
    Clin Evid; 2002 Dec; (8):1370-85. PubMed ID: 12603943
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dystonia and Parkinson's disease.
    Carella F, Giovannini P, Girotti F, Testa D, Caraceni T.
    Adv Neurol; 1993 Dec; 60():558-61. PubMed ID: 8420191
    [No Abstract] [Full Text] [Related]

  • 11. Anticholinergics and dyskinesia.
    Linazasoro G.
    Mov Disord; 1994 Nov; 9(6):689. PubMed ID: 7845412
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Levodopa+selegiline combination and increase of risk of mortality in the treatment of Parkinson disease].
    Dubois B, Montastruc JL.
    Rev Neurol (Paris); 1996 Feb; 152(2):103-5. PubMed ID: 8761616
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease.
    Heinonen E, Myllylä V.
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):280-2. PubMed ID: 9703195
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.